Partner content Powered air-purifying respirators: a necessity for small molecule API manufacturing In 2022, there is still significant demand for small molecule API manufacturing. GlobalData’s Drugs database indicates that 97% of marketed…
Meeting the demand for potent product handling in a sterile environment Active Pharmaceutical Ingredients (API) are generally becoming more potent, with occupational exposure limits (OEL) of 1µg/m3 now being considered the norm. Just ten years ago, this would have been a rare occurrence, but as the…
To clean or not to clean? Why single use is better for pharma HPAPI containment Pharmaceutical drug development is continually challenged to provide better compounds to treat a wide range of disease and illness.
Partner content How “just in time” hydration of cell culture media can be optimised by single-use powder handling
How to prevent contamination in a biopharmaceutical manufacturing operation Unlike traditional pharmaceuticals, biopharmaceuticals are a result of the genetic manipulation of living cells. Developing these extremely complex structures comes… а>
Partner content Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)
Powder containment experts: Interview with ILC Dover chief executive Fran DiNuzzo Interview with ILC Dover chief executive Fran DiNuzzo: Why the US-based company are experts when it comes to powder handling in the pharmaceutical manufacturing process.